vs
Eventbrite, Inc.（EB）与IRONWOOD PHARMACEUTICALS INC（IRWD）财务数据对比。点击上方公司名可切换其他公司
Eventbrite, Inc.的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.5倍（$73.5M vs $47.7M），IRONWOOD PHARMACEUTICALS INC净利率更高（-4.8% vs -11.1%，领先6.3%），Eventbrite, Inc.同比增速更快（-3.9% vs -47.3%），IRONWOOD PHARMACEUTICALS INC自由现金流更多（$74.6M vs $-60.9M），过去两年Eventbrite, Inc.的营收复合增速更高（-7.7% vs -20.2%）
Eventbrite是源自美国的线下活动服务平台，为用户提供活动浏览、创建与推广服务，支持主办方免费在平台发布不限规模、不限数量的各类活动，是全球范围内活跃度较高的活动交易与推广平台。
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
EB vs IRWD — 直观对比
营收规模更大
EB
是对方的1.5倍
$47.7M
营收增速更快
EB
高出43.4%
-47.3%
净利率更高
IRWD
高出6.3%
-11.1%
自由现金流更多
IRWD
多$135.4M
$-60.9M
两年增速更快
EB
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $73.5M | $47.7M |
| 净利润 | $-8.2M | $-2.3M |
| 毛利率 | 68.1% | — |
| 营业利润率 | -12.4% | 14.3% |
| 净利率 | -11.1% | -4.8% |
| 营收同比 | -3.9% | -47.3% |
| 净利润同比 | 2.5% | -200.9% |
| 每股收益（稀释后） | $-0.08 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EBIRWD
| Q4 25 | $73.5M | $47.7M | ||
| Q3 25 | $71.7M | $122.1M | ||
| Q2 25 | $72.8M | $85.2M | ||
| Q1 25 | $73.8M | $41.1M | ||
| Q4 24 | $76.5M | $90.5M | ||
| Q3 24 | $77.8M | $91.6M | ||
| Q2 24 | $84.6M | $94.4M | ||
| Q1 24 | $86.3M | $74.9M |
净利润EBIRWD
| Q4 25 | $-8.2M | $-2.3M | ||
| Q3 25 | $6.4M | $40.1M | ||
| Q2 25 | $-2.1M | $23.6M | ||
| Q1 25 | $-6.6M | $-37.4M | ||
| Q4 24 | $-8.4M | $2.3M | ||
| Q3 24 | $-3.8M | $3.6M | ||
| Q2 24 | $1.1M | $-860.0K | ||
| Q1 24 | $-4.5M | $-4.2M |
毛利率EBIRWD
| Q4 25 | 68.1% | — | ||
| Q3 25 | 67.9% | — | ||
| Q2 25 | 67.5% | — | ||
| Q1 25 | 66.9% | — | ||
| Q4 24 | 68.2% | — | ||
| Q3 24 | 68.5% | — | ||
| Q2 24 | 70.9% | — | ||
| Q1 24 | 71.0% | — |
营业利润率EBIRWD
| Q4 25 | -12.4% | 14.3% | ||
| Q3 25 | -1.3% | 61.8% | ||
| Q2 25 | -8.7% | 53.2% | ||
| Q1 25 | -13.2% | -70.7% | ||
| Q4 24 | -10.2% | 34.8% | ||
| Q3 24 | -11.5% | 28.0% | ||
| Q2 24 | -7.6% | 26.5% | ||
| Q1 24 | -8.8% | 14.7% |
净利率EBIRWD
| Q4 25 | -11.1% | -4.8% | ||
| Q3 25 | 8.9% | 32.8% | ||
| Q2 25 | -2.9% | 27.7% | ||
| Q1 25 | -9.0% | -90.9% | ||
| Q4 24 | -11.0% | 2.5% | ||
| Q3 24 | -4.8% | 4.0% | ||
| Q2 24 | 1.3% | -0.9% | ||
| Q1 24 | -5.2% | -5.6% |
每股收益（稀释后）EBIRWD
| Q4 25 | $-0.08 | $0.01 | ||
| Q3 25 | $0.06 | $0.23 | ||
| Q2 25 | $-0.02 | $0.14 | ||
| Q1 25 | $-0.07 | $-0.23 | ||
| Q4 24 | $-0.09 | $0.03 | ||
| Q3 24 | $-0.04 | $0.02 | ||
| Q2 24 | $0.01 | $-0.01 | ||
| Q1 24 | $-0.05 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $299.9M | $215.5M |
| 总债务越低越好 | $144.4M | — |
| 股东权益账面价值 | $179.1M | $-261.8M |
| 总资产 | $647.2M | $396.9M |
| 负债/权益比越低杠杆越低 | 0.81× | — |
8季度趋势，按日历期对齐
现金及短期投资EBIRWD
| Q4 25 | $299.9M | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | — | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | $441.5M | $88.6M | ||
| Q3 24 | $24.7M | $88.2M | ||
| Q2 24 | $56.7M | $105.5M | ||
| Q1 24 | $113.7M | $121.5M |
总债务EBIRWD
| Q4 25 | $144.4M | — | ||
| Q3 25 | $174.9M | $199.5M | ||
| Q2 25 | $241.3M | $199.3M | ||
| Q1 25 | $241.0M | $199.2M | ||
| Q4 24 | $240.7M | $199.0M | ||
| Q3 24 | $240.4M | $198.8M | ||
| Q2 24 | $358.7M | $198.6M | ||
| Q1 24 | $358.2M | $398.3M |
股东权益EBIRWD
| Q4 25 | $179.1M | $-261.8M | ||
| Q3 25 | $189.1M | $-264.2M | ||
| Q2 25 | $177.2M | $-308.2M | ||
| Q1 25 | $173.3M | $-334.1M | ||
| Q4 24 | $170.2M | $-301.3M | ||
| Q3 24 | $179.8M | $-311.3M | ||
| Q2 24 | $176.2M | $-321.7M | ||
| Q1 24 | $184.1M | $-330.5M |
总资产EBIRWD
| Q4 25 | $647.2M | $396.9M | ||
| Q3 25 | $744.6M | $396.1M | ||
| Q2 25 | $784.1M | $342.9M | ||
| Q1 25 | $812.3M | $327.2M | ||
| Q4 24 | $752.3M | $350.9M | ||
| Q3 24 | $817.4M | $389.5M | ||
| Q2 24 | $894.5M | $395.6M | ||
| Q1 24 | $952.2M | $438.8M |
负债/权益比EBIRWD
| Q4 25 | 0.81× | — | ||
| Q3 25 | 0.92× | — | ||
| Q2 25 | 1.36× | — | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 1.41× | — | ||
| Q3 24 | 1.34× | — | ||
| Q2 24 | 2.04× | — | ||
| Q1 24 | 1.95× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-60.8M | $74.6M |
| 自由现金流经营现金流 - 资本支出 | $-60.9M | $74.6M |
| 自由现金流率自由现金流/营收 | -82.8% | 156.3% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $17.6M | $127.0M |
8季度趋势，按日历期对齐
经营现金流EBIRWD
| Q4 25 | $-60.8M | $74.6M | ||
| Q3 25 | $36.7M | $47.6M | ||
| Q2 25 | $-17.5M | $-15.1M | ||
| Q1 25 | $59.4M | $20.0M | ||
| Q4 24 | $-45.3M | $15.2M | ||
| Q3 24 | $44.6M | $9.9M | ||
| Q2 24 | $-32.3M | $33.5M | ||
| Q1 24 | $68.6M | $45.0M |
自由现金流EBIRWD
| Q4 25 | $-60.9M | $74.6M | ||
| Q3 25 | $36.6M | $47.6M | ||
| Q2 25 | $-17.5M | $-15.1M | ||
| Q1 25 | $59.4M | $19.9M | ||
| Q4 24 | $-45.3M | — | ||
| Q3 24 | $44.4M | $9.9M | ||
| Q2 24 | $-32.4M | $33.4M | ||
| Q1 24 | $68.2M | $44.9M |
自由现金流率EBIRWD
| Q4 25 | -82.8% | 156.3% | ||
| Q3 25 | 51.1% | 39.0% | ||
| Q2 25 | -24.1% | -17.7% | ||
| Q1 25 | 80.4% | 48.4% | ||
| Q4 24 | -59.2% | — | ||
| Q3 24 | 57.1% | 10.8% | ||
| Q2 24 | -38.3% | 35.4% | ||
| Q1 24 | 79.1% | 60.0% |
资本支出强度EBIRWD
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.2% | 0.0% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.4% | 0.1% |
现金转化率EBIRWD
| Q4 25 | — | — | ||
| Q3 25 | 5.76× | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | -30.37× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EB
| US | $52.0M | 71% |
| Other | $21.6M | 29% |
IRWD
暂无分部数据
